Product Program year 2020 Source: CMS Open Payments

Ain457f_Cosentyx_Immunology

Biological Immunology

NDC 0078-0639-41

Open in the dashboard

General payments

$315,487

147 payments

Research payments

$163,906

34 payments

Through program year 2020, $315,487 in general payments and $163,906 in research payments were reported against Ain457f_Cosentyx_Immunology (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows

General

’19 ’20

Peak $277K

Research

’19 ’20

Peak $84K

Year	Kind	Amount	Payments
2020	General	$38,554	13
2020	Research	$79,680	17
2019	General	$276,933	134
2019	Research	$84,226	17

Breakdown

Who paid General payments · program years 2019–2020

Novartis Pharma AG $315,487 147 payments

Top recipients General payments · program year 2020

Grace Wright Rheumatology · New York, NY $20,930 54% · 7 payments
Atulya Deodhar Rheumatology · Portland, OR $8,762 23% · 2 payments
Philip Mease Rheumatology · Seattle, WA $7,347 19% · 3 payments
Joerg Ermann Rheumatology · Boston, MA $1,515 4% · 1 payment

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020

Rheumatology Internal Medicine $38,554 100% · 4 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020

New York $20,930 54% · 1 recipient
Oregon $8,762 23% · 1 recipient
Washington $7,347 19% · 1 recipient
Massachusetts $1,515 4% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

Records

147 general · 34 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.